Published in Cancer Weekly, July 22nd, 1996
Two protocols were evaluated in more than 1,800 women. The B-13 arm of the study evaluated the sequential administration of methotrexate followed by fluorouracil in 760 patients, while the B-19 arm compared sequential methotrexate-fluorouracil with conventional cyclophosphamide/methotrexate/fluorouracil (CMF) in 1,095 others. The report appeared in the July 1996 Journal of Clinical Oncology (J Clin Oncol...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.